Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial

OBJECTIVE: Simplification of antiretroviral therapy in patients with suppressed viremia may minimize long-term adverse effects. The study’s primary objective was to determine whether abacavir/lamivudine + atazanavir (ABC/3TC+ATV) was virologically non-inferior to tenofovir/emtricitabine + atazanavir...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohl, David A., Bhatti, Laveeza, Small, Catherine B., Edelstein, Howard, Zhao, Henry H., Margolis, David A., DeJesus, Edwin, Weinberg, Winkler G., Ross, Lisa L., Shaefer, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019479/
https://www.ncbi.nlm.nih.gov/pubmed/24825167
http://dx.doi.org/10.1371/journal.pone.0096187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019479/
https://www.ncbi.nlm.nih.gov/pubmed/24825167
http://dx.doi.org/10.1371/journal.pone.0096187

Ejemplares similares